DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
LYRA Lyra Therapeutics
- 0.208
- -0.002-0.86%
Close Feb 14 16:00 ET
- 0.214
- +0.006+2.98%
Post 20:01 ET
13.63MMarket Cap-0.14P/E (TTM)
0.216High0.203Low1.52MVolume0.210Open0.210Pre Close318.44KTurnover3.65%Turnover RatioLossP/E (Static)65.46MShares6.79052wk High0.66P/B8.68MFloat Cap0.16352wk Low--Dividend TTM41.71MShs Float22.000Historical High--Div YieldTTM6.52%Amplitude0.163Historical Low0.209Avg Price1Lot Size
About Lyra Therapeutics Company
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.
Company Profile
SymbolLYRA
Company NameLyra Therapeutics
Listing DateMay 1, 2020
Issue Price16.00
Founded2005
CEODr. Maria Palasis, PhD
MarketNASDAQ
Employees145
Fiscal Year Ends12-31
Address480 Arsenal Way
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-393-4600
Company Executives
- Name
- Position
- Salary
- Dr. Maria Palasis, PhD
- Director, President and Chief Executive Officer
- 1.79M
- Jason Cavalier
- Chief Financial Officer, Treasurer and Principal Accounting Officer
- --
- Dr. Richard Nieman
- Chief Medical Officer
- --
- Dr. Harlan W. Waksal,M.D.
- Executive Chairman of the Board
- 625.06K
- James R. Tobin
- Lead Independent Director
- 152.31K
- C. Ann Merrifield
- Independent Director
- 113.06K
- W. Bradford Smith
- Independent Director
- 123.81K
- Dr. Nancy L. Snyderman, F.A.C.S.,M.D.
- Independent Director
- 109.06K